PGR and triple-negative breast carcinoma: Triple-negative breast cancer (TNBC), accounting for about 15–20% of total, is a subtype characterized by lack of estrogen receptor (ER) and progesterone receptor (PR) expression and lack of ERBB2 (also known as HER2) amplification (Foulkes et al., 2010).